When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - Alexion to launch study of Ultomiris in ALS
Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals (ALXN-2%) plans to launch a late-stage study, CHAMPION-ALS, this quarter evaluating Ultomiris (ravulizumab-cwvz) in patients with amyotrophic lateral sclerosis (ALS).
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,